Autoimmune lymphoproliferative syndrome secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Autoimmune lymphoproliferative syndrome}}
{{Autoimmune lymphoproliferative syndrome}}
{{CMG}} {{AE}}
{{CMG}} {{AE}}{{SharmiB}}
 
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 
==Overview==
==Overview==
There is no established [[secondary]] [[prevention]] method for [[ALPS]]. But regular monitoring for [[lymphoma]] and proper [[vaccination]] for the [[patients]] requiring [[splenectomy]] might be helpful.
There is no established [[secondary]] [[prevention]] method for [[ALPS]]. But regular monitoring for [[lymphoma]] and proper [[vaccination]] for the [[patients]] requiring [[splenectomy]] might be helpful.


==Secondary Prevention==
==Secondary Prevention==
Individuals who require to get splenectomy should be [[vaccinated]] and have [[penicillin]] [[prophylaxis]] to prevent the [[complications]].{{cite web |url=https://www.ncbi.nlm.nih.gov/books/ |title=Home - Books - NCBI |format= |work= |accessdate=}}
Individuals who require to get splenectomy should be [[vaccinated]] and have [[penicillin]] [[prophylaxis]] to prevent the [[complications]].<ref name="pmid20301287">{{cite journal| author=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G | display-authors=etal| title=GeneReviews® | journal= | year= 1993 | volume=  | issue=  | pages=  | pmid=20301287 | doi= | pmc= | url= }} </ref>


==References==
==References==
Line 15: Line 12:


[[Category:Hematology]]
[[Category:Hematology]]
{{WH}}
{{WS}}

Latest revision as of 04:16, 3 August 2021

Autoimmune lymphoproliferative syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune lymphoproliferative syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune lymphoproliferative syndrome secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune lymphoproliferative syndrome secondary prevention

CDC on Autoimmune lymphoproliferative syndrome secondary prevention

Autoimmune lymphoproliferative syndrome secondary prevention in the news

Blogs on Autoimmune lymphoproliferative syndrome secondary prevention

Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome

Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Overview

There is no established secondary prevention method for ALPS. But regular monitoring for lymphoma and proper vaccination for the patients requiring splenectomy might be helpful.

Secondary Prevention

Individuals who require to get splenectomy should be vaccinated and have penicillin prophylaxis to prevent the complications.[1]

References

  1. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G; et al. (1993). "GeneReviews®". PMID 20301287.